FOXM1 overexpression reduced venetoclax sensitivity of AML by stabilizing BCL2A1; this effect was recapitulated by BCL2A1 overexpression with no significant change in FOXM1 expression levels. The gene discussed is FOXM1; the disease is acute myeloid leukemia.